Development of radiolabelled compounds with improved metabolic stability, pharmacokinetics and binding selectivity for non-invasive imaging of parenchymal and vascular ß-amyloid plaues in Morbus Alzheimer by means of positron emission tomograpy (PET).

• Applicant: Professor Dr. Hans-Jürgen Wester, since 1/2012
• Subject Area: Pharmacy
• Term: from 2005 to 2016
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 5445907

No abstract available

• DFG Programme: Research Grants
• Participating Person: Professor Dr. Alexander Drzezga
• Ehemaliger Antragsteller: Dr. Gjermund Henriksen, until 1/2012